The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
The “Toll” of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia
Open accessAbstract
Glial activation participates in the mediation of pain including neuropathic pain, due to release of neuroexcitatory, proinflammatory products. Glial activation is now known to occur in response to opioids as well. Opioid-induced glial activation opposes opioid analgesia and enhances opioid tolerance, dependence, reward and respiratory depression. Such effects can occur, not via classical opioid receptors, but rather via non-stereoselective activation of toll-like receptor 4 (TLR4), a recently recognized key glial receptor participating in neuropathic pain as well. This discovery identifies a means for separating the beneficial actions of opioids (opioid receptor mediated) from the unwanted side-effects (TLR4/glial mediated) by pharmacologically targeting TLR4. Such a drug should be a stand-alone therapeutic for treating neuropathic pain as well. Excitingly, with newly-established clinical trials of two glial modulators for treating neuropathic pain and improving the utility of opioids, translation from rats-to-humans now begins with the promise of improved clinical pain control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The blockade of glial cell activation restored mesolimbic dopamine function using minocycline (Taylor et al., 2016), prevented withdrawal using various inhibitors of glial cell activation (Watkins et al., 2009), prevented the relapse of morphine-seeking behavior via the epigenetic reprogramming of interleukin-10 overexpression (Schwarz et al., 2011), and prevented incubation-induced heroin seeking”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Watkins et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The acute administration of opioids exerts anti-inflammatory effects (Eisenstein, 2019), whereas chronic opioid exposure activates microglia and astrocytes in the spinal cord (Watkins et al., 2009;Cahill et al., 2016) and central nervous system, including the VTA, NAc, frontal cortex, and periaqueductal gray (Hao et al., 2011;Taylor et al., 2016).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Watkins et al., 2009
In the citing paper
“Moreover, an overwhelming amount of evidence demonstrates that within the CNS, opioid administration leads to the activation of microglia via a toll-like receptor (TLR)-4-dependent mechanism, and produces paradoxical aggravation of proinflammatory immune responses (Hutchinson et al, 2007;Watkins et al, 2009).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Watkins et al, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Obata, K., Katsura, H., Miyoshi, K., Kondo, T., Yamanaka, H., Kobayashi, K., Dai, Y., Fukuoka, T., Akira, S., & Noguchi, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05353.x · Cited by 80
RetractedATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
Pathological and protective roles of glia in chronic pain
Milligan, E. D., & Watkins, L. R. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2533 · Cited by 1,443
Self-citationVasudeva, R., Tanga, F. Y., & DeLeo, J. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052407 · Cited by 797
Ledeboer, A., Sloane, E. M., Milligan, E. D., Frank, M. G., Mahony, J. H., Maier, S. F., & Watkins, L. R. (2005) · Pain · doi:10.1016/j.pain.2005.02.009 · Cited by 677
Self-citationGLIA: A novel drug discovery target for clinical pain
Watkins, L. R., & Maier, S. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1251 · Cited by 674
Self-citationNociceptors Are Interleukin-1β Sensors
Binshtok, A. M., Wang, H., Zimmermann, K., Amaya, F., Vardeh, D., Shi, L., Brenner, G. J., Ji, R., Bean, B. P., Woolf, C. J., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3795-08.2008 · Cited by 664
The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy
Tanga, F. Y., Nutile-McMenemy, N., & DeLeo, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501634102 · Cited by 634
Evidence that opioids may have toll-like receptor 4 and MD-2 effects
Hutchinson, M. R., Zhang, Y., Shridhar, M., Evans, J. H., Buchanan, M. M., Zhao, T. X., Slivka, P. F., Coats, B. D., Rezvani, N., Wieseler, J. L., et al. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.08.004 · Cited by 575
Self-citationRock, C. S., & Lowry, S. F. (1991) · Journal of Surgical Research · doi:10.1016/0022-4804(91)90146-d · Cited by 506
Jin, X., & Gereau, R. W. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3858-05.2006 · Cited by 488
Glial–Cytokine–Neuronal Interactions Underlying the Mechanisms of Persistent Pain
Guo, W., Wang, H., Watanabe, M., Shimizu, K., Zou, S., LaGraize, S. C., Wei, F., Dubner, R. A., & Ren, K. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0176-07.2007 · Cited by 480
Vasudeva, R., Rutkowski, M. D., & DeLeo, J. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09980.2002 · Cited by 468
The involvement of glial cells in the development of morphine tolerance
Song, P., & Zhao, Z.-Q. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(00)00226-1 · Cited by 445
Johnston, I. N., Milligan, E. D., Wieseler‐Frank, J., Frank, M. G., Zapata, V., Campisi, J., Langer, S. J., Martin, D., Green, P., Fleshner, M., et al. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1850-04.2004 · Cited by 440
Self-citationHutchinson, M. R., Zhang, Y., Brown, K., Coats, B. D., Shridhar, M., Sholar, P. W., Patel, S. J., Crysdale, N. Y., Harrison, J. A., Maier, S. F., et al. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06321.x · Cited by 399
Self-citationHutchinson, M. R., Bland, S. T., Johnson, K. W., Rice, K. C., Maier, S. F., & Watkins, L. R. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.230 · Cited by 359
Self-citationTLR4/MyD88/PI3K interactions regulate TLR4 signaling.
Laird, M. H. W., Rhee, S. H., Perkins, D. J., Medvedev, A. E., Piao, W., Fenton, M. J., & Vogel, S. N. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1208763 · Cited by 342
Glia: novel counter-regulators of opioid analgesia
Watkins, L. R., Hutchinson, M. R., Johnston, I. N., & Maier, S. F. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.10.001 · Cited by 327
Self-citationSupraspinal Glial–Neuronal Interactions Contribute to Descending Pain Facilitation
Wei, F., Guo, W., Zou, S., Ren, K., & Dubner, R. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3593-08.2008 · Cited by 322
Kim, D., Kim, M. A., Cho, I., Kim, M. S., Lee, S., Jo, E., Choi, S., Park, K., Kim, J. S., Akira, S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607277200 · Cited by 315
Ledeboer, A., Jekich, B. M., Sloane, E. M., Mahoney, J. H., Langer, S. J., Milligan, E. D., Martin, D., Maier, S. F., Johnson, K. W., Leinwand, L. A., et al. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.10.012 · Cited by 310
Self-citationProinflammatory cytokines oppose opioid-induced acute and chronic analgesia
Hutchinson, M. R., Coats, B. D., Lewis, S. S., Zhang, Y., Sprunger, D. B., Rezvani, N., Baker, E. M., Jekich, B. M., Wieseler, J. L., Somogyi, A. A., et al. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.05.004 · Cited by 307
Self-citationHutchinson, M. R., Lewis, S. S., Coats, B. D., Skyba, D. A., Crysdale, N. Y., Berkelhammer, D. L., Brzeski, A., Northcutt, A. L., Vietz, C. M., Judd, C. M., et al. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.09.012 · Cited by 306
Self-citationMicroglia and neuropathic pain
Inoue, K., & Tsuda, M. (2009) · Glia · doi:10.1002/glia.20871 · Cited by 294
Mika, J., Osikowicz, M., Makuch, W., & Przewłocka, B. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.013 · Cited by 291
Raghavendra, V., Tanga, F. Y., & DeLeo, J. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300315 · Cited by 263
Potentiation of Opiate Analgesia and Apparent Reversal of Morphine Tolerance by Proglumide
Watkins, L. R., Kinscheck, I. B., & Mayer, D. J. (1984) · Science · doi:10.1126/science.6546809 · Cited by 259
Self-citationSpinal glial activation contributes to pathological pain states
Cao, H., & Zhang, Y. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.009 · Cited by 248
Chauveau, F., Camp, N. V., Dollé, F., Kühnast, B., Hinnen, F., Damont, A., Boutin, H., James, M. L., Kassiou, M., & Tavitian, B. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.058669 · Cited by 236
Role of spinal microglia in rat models of peripheral nerve injury and inflammation
Clark, A. K., Gentry, C., Bradbury, E. J., McMahon, S. B., & Malcangio, M. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2006.02.003 · Cited by 235
Contribution of the activation of satellite glia in sensory ganglia to pathological pain
Takeda, M., Takahashi, M., & Matsumoto, S. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.12.005 · Cited by 227
Morphine Enhances Microglial Migration through Modulation of P2X4Receptor Signaling
Horvath, R. J., & DeLeo, J. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4595-08.2009 · Cited by 219
Narita, M., Miyatake, M., Narita, M., Shibasaki, M., Shindo, K., Nakamura, A., Kuzumaki, N., Nagumo, Y., & Suzuki, T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301007 · Cited by 218
Milligan, E. D., Langer, S. J., Sloane, E. M., He, L., Wieseler‐Frank, J., O’Connor, K., Martin, D., Forsayeth, J., Maier, S. F., Johnson, K. W., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04057.x · Cited by 217
Self-citationOpioid Tolerance and Hyperalgesia
Chang, G., Chen, L. L., & Mao, J. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.10.003 · Cited by 210
Cui, Y., Liao, X., Liu, W., Guo, R., Wu, Z.-Z., Zhao, C., Chen, P., & Feng, J. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.07.014 · Cited by 207
Watkins, L. R., Hutchinson, M. R., Milligan, E. D., & Maier, S. F. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.06.006 · Cited by 185
Self-citationModulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness.
Mika, J. (2008) · PubMed · Cited by 184
Zhang, R.-X., Li, A., Liu, B., Wang, L., Ren, K., Zhang, H., Berman, B., & Lao, L. (2007) · Pain · doi:10.1016/j.pain.2007.05.023 · Cited by 183
Milligan, E. D., Sloane, E. M., Langer, S. J., Cruz, P. E., Chacur, M., Spataro, L. E., Wieseler‐Frank, J., Hammack, S. E., Maier, S. F., Flotte, T. R., et al. (2005) · Molecular Pain · doi:10.1186/1744-8069-1-9 · Cited by 181
Self-citationHutchinson, M. R., Northcutt, A. L., Chao, L. W., Kearney, J. J., Zhang, Y., Berkelhammer, D. L., Loram, L. C., Rozeske, R. R., Bland, S. T., Maier, S. F., et al. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.07.008 · Cited by 180
Self-citationInterleukin-1 antagonizes morphine analgesia and underlies morphine tolerance
Shavit, Y., Wolf, G., Goshen, I., Livshits, D., & Yirmiya, R. (2005) · Pain · doi:10.1016/j.pain.2005.02.003 · Cited by 176
Cui, Y., Chen, Y., Zhi, J., Guo, R., Feng, J., & Chen, P. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.066 · Cited by 173
Effects of Etanercept and Minocycline in a rat model of spinal cord injury
Marchand, F., Tsantoulas, C., Singh, D., Grist, J., Clark, A. K., Bradbury, E. J., & McMahon, S. B. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2008.08.001 · Cited by 169
Romero-Sandoval, A., Nutile-McMenemy, N., & DeLeo, J. A. (2008) · Anesthesiology · doi:10.1097/aln.0b013e318167af74 · Cited by 168
Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice
Mika, J., Wawrzczak‐Bargieła, A., Osikowicz, M., Makuch, W., & Przewłocka, B. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.07.005 · Cited by 163
Ledeboer, A., Hutchinson, M. R., Watkins, L. R., & Johnson, K. W. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.935 · Cited by 153
Self-citationThe glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release
Bland, S. T., Hutchinson, M. R., Maier, S. F., Watkins, L. R., & Johnson, K. W. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.01.014 · Cited by 152
Self-citationAltered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients
Backonja, M. “., Coe, C. L., Muller, D. A., & Schell, K. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.01.005 · Cited by 149
Gwak, Y. S., Crown, E. D., Unabia, G. C., & Hulsebosch, C. E. (2008) · Pain · doi:10.1016/j.pain.2008.01.021 · Cited by 143
Liu, Y., Zhou, L., Hu, N., Xu, J., Wu, C. Y., Zhang, T., Li, Y.-Y., & Liu, X. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.09.011 · Cited by 142
Neuroimmune interactions and pain: focus on glial-modulating targets.
Romero-Sandoval, E. A., Horvath, R. J., & DeLeo, J. A. (2008) · PubMed · Cited by 140
Valle, L. D., Schwartzman, R. J., & Alexander, G. M. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.08.004 · Cited by 139
Tawfik, V. L., Nutile‐McMenemy, N., LaCroix‐Fralish, M. L., & DeLeo, J. A. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.07.001 · Cited by 136
Padi, S. S. V., & Kulkarni, S. K. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.018 · Cited by 134
Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries
Zhang, D. X., Zou, A.-P., & Li, P. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00697.2002 · Cited by 124
Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury
Banati, R. B., Cagnin, A., Brooks, D. J., Gunn, R. N., Myers, R., Jones, T., Birch, R., & Anand, P. (2001) · Neuroreport · doi:10.1097/00001756-200111160-00012 · Cited by 123
Romero-Sandoval, A. E., & Eisenach, J. C. (2007) · Anesthesiology · doi:10.1097/01.anes.0000264765.33673.6c · Cited by 122
The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain
Ledeboer, A., Liu, T., Shumilla, J. A., Mahoney, J. H., Vijay, S., Gross, M. I., Vargas, J. A., Sultzbaugh, L., Claypool, M. D., Sanftner, L. M., et al. (2006) · Neuron Glia Biology · doi:10.1017/s1740925x0700035x · Cited by 122
Self-citationThe contributing role of CD14 in toll-like receptor 4 dependent neuropathic pain
Cao, L., Tanga, F. Y., & DeLeo, J. A. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.004 · Cited by 114
Mechanisms underlying morphine analgesic tolerance and dependence
Ueda, H. (2009) · Frontiers in bioscience · doi:10.2741/3596 · Cited by 109
Sloane, E. M., Ledeboer, A., Seibert, W., Coats, B. D., van Strien, M. E., Maier, S. F., Johnson, K. W., Chavez, R. A., Watkins, L. R., Leinwand, L. A., et al. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.09.004 · Cited by 105
Self-citationChanges in immune and glial markers in the CSF of patients with Complex Regional Pain Syndrome
Alexander, G. M., Perreault, M. J., Reichenberger, E. R., & Schwartzman, R. J. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.10.009 · Cited by 105
Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse?
Haydon, P. G., Blendy, J. A., Moss, S. J., & Jackson, F. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.050 · Cited by 103
The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats
Cata, J. P., Weng, H., & Dougherty, P. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.001 · Cited by 102
Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation
Bhat, R. S., Bhaskaran, M. C., Mongia, A. K., Hitosugi, N., & Singhal, P. C. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1203639 · Cited by 99
Takeda, M., Kitagawa, J., Takahashi, M., & Matsumoto, S. (2008) · Pain · doi:10.1016/j.pain.2008.06.015 · Cited by 98
Morphine-Induced Chemotaxis and Brain-Derived Neurotrophic Factor Expression in Microglia
Takayama, N., & Ueda, H. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3170-04.2005 · Cited by 97
Whiteside, G. T., Gottshall, S. L., Boulet, J. M., Chaffer, S. M., Harrison, J., Pearson, M. S., Turchin, P. I., Mark, L., Garrison, A. E., & Valenzano, K. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.043 · Cited by 94
Roberts, J., Ossipov, M. H., & Porreca, F. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06813.x · Cited by 89
Terayama, R., Omura, S., Fujisawa, N., Yamaai, T., Ichikawa, H., & Sugimoto, T. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.041 · Cited by 88
Hutchinson, M. R., Ramos, K. M., Loram, L. C., Wieseler, J. L., Sholar, P. W., Kearney, J. J., Lewis, M. T., Crysdale, N. Y., Zhang, Y., Harrison, J. A., et al. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.09.046 · Cited by 87
Self-citationNaguib, M., Diaz, P., Xu, J. J., Astruc‐Diaz, F., Craig, S., Vivas‐Mejia, P., & Brown, D. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.340 · Cited by 82
Pentoxifylline attenuates the development of hyperalgesia in a rat model of neuropathic pain
Liu, J., Feng, X., Yu, M., Xie, W., Zhao, X., Li, W., Guan, R., & Xu, J. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.11.022 · Cited by 82
Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress
Qin, L., Block, M. L., Liu, Y., Bienstock, R. J., Pei, Z., Zhang, W., Wu, X., Wilson, B. C., Burka, T., & Hong, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2857com · Cited by 81
Zhang, R.-X., Liu, B., Li, A., Wang, L., Ren, K., Qiao, J.-T., Berman, B., & Lao, L. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.04.072 · Cited by 81
Acid Sphingomyelinase Is Required for Lipid Raft TLR4 Complex Formation
Cuschieri, J., Bulger, E. M., Billgrin, J., Garcia, I. A., & Maier, R. V. (2007) · Surgical Infections · doi:10.1089/sur.2006.050 · Cited by 80
Differential regulation of microglial activation by propentofylline via cAMP signaling
Si, Q., Nakamura, Y., Ogata, T., Kataoka, K., & Schubert, P. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00954-8 · Cited by 79
Propentofylline attenuates vincristine-induced peripheral neuropathy in the rat
Sweitzer, S. M., Pahl, J. L., & DeLeo, J. A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.02.058 · Cited by 77
Nociception increases during opioid infusion in opioid receptor triple knock-out mice
Juni, A., Klein, G. E., Pintar, J. E., & Kest, B. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.04.030 · Cited by 75
Ndengele, M. M., Cuzzocrea, S., Masini, E., Vinci, M. C., Esposito, E., Muscoli, C., Petrusca, D. N., Mollace, V., Mazzon, E., Li, D., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146290 · Cited by 72
Implication of Activated Astrocytes in the Development of Drug Dependence
Narita, M., Suzuki, M., Kuzumaki, N., Miyatake, M., & Suzuki, T. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.032 · Cited by 72
Wei, T., Sabsovich, I., Guo, T., Shi, X., Zhao, R., Li, W., Geis, C., Sommer, C., Kingery, W. S., & Clark, J. D. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2008.04.014 · Cited by 67
Wieseler, J. L., Ellis, A., Sprunger, D. B., Brown, K., McFadden, A., Mahoney, J. H., Rezvani, N., Maier, S. F., & Watkins, L. R. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.10.006 · Cited by 65
Self-citationKleibeuker, W., Gabay, E., Kavelaars, A., Zijlstra, J., Wolf, G., Ziv, N., Yirmiya, R., Shavit, Y., Tal, M., & Heijnen, C. J. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.07.009 · Cited by 64
Merskey, H., Loeser, J. D., & Dubner, R. A. (2005) · Medical Entomology and Zoology · Cited by 62
Noman, A. S. M., Koide, N., Hassan, F., Iftakhar-E-Khuda, I., Dagvadorj, J., Tumurkhuu, G., Islam, S., Naiki, Y., Yoshida, T., & Yokochi, T. (2009) · Innate Immunity · doi:10.1177/1753425908099317 · Cited by 62
Wolf, G., Livshits, D., Beilin, B., Yirmiya, R., & Shavit, Y. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.03.005 · Cited by 60
Tawfik, V. L., LaCroix‐Fralish, M. L., Nutile‐McMenemy, N., & DeLeo, J. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082420 · Cited by 60
Chacur, M., Lambertz, D., Hoheisel, U., & Mense, S. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2008.11.008 · Cited by 58
Lin, C., Tsaur, M.-L., CHEN, C., WANG, T., Lin, C., Lai, Y.-J., HSU, T., PAN, Y., YANG, C., & CHENG, J. (2007) · Regional Anesthesia & Pain Medicine · doi:10.1016/j.rapm.2007.01.005 · Cited by 57
Wieseler‐Frank, J., Jekich, B. M., Mahoney, J. H., Bland, S. T., Maier, S. F., & Watkins, L. R. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.07.004 · Cited by 55
Self-citationTsai, R., Jang, F.-L., Tai, Y.-H., Lin, S., Shen, C., & Wong, C. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301672 · Cited by 53
Lu, C., Chao, P., Borel, C. O., Yang, C.-P., Yeh, C., Wong, C., & Wu, C. (2004) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000132974.32249.c8 · Cited by 51
Weber, M., Modemann, S., Schipper, P., Trauer, H., Franke, H., Illés, P., Geiger, K. D., Hengstler, J. G., & Kleemann, W. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.11.059 · Cited by 51
A Peptide Antagonist of the TLR4–MD2 Interaction
Slivka, P. F., Shridhar, M., Lee, G., Sammond, D. W., Hutchinson, M. R., Martinko, A. J., Buchanan, M. M., Sholar, P. W., Kearney, J. J., Harrison, J. A., et al. (2009) · ChemBioChem · doi:10.1002/cbic.200800769 · Cited by 50
Self-citationTan, A. M., Zhao, P., Waxman, S. G., & Hains, B. C. (2009) · PubMed · Cited by 50
Microglia: a newly discovered role in visceral hypersensitivity?
Saab, C. Y., Wang, J., Gu, C., Garner, K. N., & Al–Chaer, E. D. (2006) · Neuron Glia Biology · doi:10.1017/s1740925x07000439 · Cited by 49
Morphine promotes apoptosis via TLR2, and this is negatively regulated by β-arrestin 2
Li, Y., Sun, X., Zhang, Y., Huang, J., Hanley, G., Ferslew, K. E., Peng, Y., & Yin, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.001 · Cited by 47
PET of Glial Metabolism Using 2-18F-Fluoroacetate
Mařı́k, J., Ogasawara, A. K., Martin-McNulty, B., Ross, J., Flores, J. E., Gill, H. S., Tinianow, J. N., Vanderbilt, A. N., Nishimura, M. C., Peale, F. V., Jr., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057356 · Cited by 47
Shen, W., Stone, K. D., Jales, A., Leitenberg, D., & Ladisch, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4425 · Cited by 46
Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependence
Liu, L., Hutchinson, M. R., White, J. M., Somogyi, A. A., & Coller, J. K. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328331e68f · Cited by 45
Self-citationPeroxynitrite: a strategic linchpin of opioid analgesic tolerance
Salvemini, D., & Neumann, W. L. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.12.005 · Cited by 41
Long-term control of neuropathic pain in a non-viral gene therapy paradigm
Sloane, E. M., Soderquist, R. G., Maier, S. F., Mahoney, M. J., Watkins, L. R., & Milligan, E. D. (2009) · Gene Therapy · doi:10.1038/gt.2009.21 · Cited by 37
Self-citationWang, S., Lim, G., Mao, J., Sung, B., & Mao, J. (2008) · Pain · doi:10.1016/j.pain.2008.10.021 · Cited by 31
Wu, H.-E., Hong, J., & Tseng, L. F. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.012 · Cited by 31
Wu, H.-E., Thompson, J., Sun, H.-S., Terashvili, M., & Tseng, L. F. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087130 · Cited by 30
Rothman, S. M., Guarino, B. B., & Winkelstein, B. A. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22090 · Cited by 28
Contribution of TLR2 to the Initiation of Ganglioside-triggered Inflammatory Signaling
Yoon, H. J., Jeon, S. B., Suk, K., Choi, D., Hong, Y., & Park, E. J. (2008) · Molecules and Cells · doi:10.1016/s1016-8478(23)17556-x · Cited by 21
Wu, H.-E., Sun, H.-S., Terashivili, M., Schwasinger, E. T., Sora, I., Hall, F. S., Uhl, G. R., & Tseng, L. F. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.012 · Cited by 19
Interleukin-1ra inhibits Fos expression and hyperalgesia in rats
Li, A., Lao, L., Wang, Y., Zhang, H., Ren, K., Berman, B., & Zhang, R.-X. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3280586839 · Cited by 7
Winkelstein, B. A., & Rothman, S. M. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.01.128 · Cited by 2
Research works printed but not linked: 3
- [45]Hutchinson MR 2009 Novel toll-like receptor 4 activity of opioids: implications for opioid analgesia and dependence Journal of Neuroscience revision in review
- [46]Lewis SS 2009 Morphine-3-glucuronide cuases enhance pain through proinflammatory glial mechanisms Neuroscience in review
- [73]Lewis SS 2009 Constriction of the facial nerve leads to increased sensitivity to somatosensory and auditory stimuli: characterization of an inflammatory and glial component Proc Soc Neurosci in press
Cited by
Sorted by citations
Neuroinflammation and Central Sensitization in Chronic and Widespread Pain
Ji, R.-R., Nackley, A., Huh, Y., Terrando, N., & Maixner, W. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002130 · Cited by 1,630
Glia and pain: Is chronic pain a gliopathy?
Ji, R., Berta, T., & Nedergaard, M. (2013) · Pain · doi:10.1016/j.pain.2013.06.022 · Cited by 1,193
Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain
Chen, G., Zhang, Y., Qadri, Y. J., Serhan, C. N., & Ji, R. (2018) · Neuron · doi:10.1016/j.neuron.2018.11.009 · Cited by 801
Morphine activates neuroinflammation in a manner parallel to endotoxin
Wang, X., Loram, L. C., Ramos, K. M., de Jesus, A. J., Thomas, J., Cheng, K., Reddy, A., Somogyi, A. A., Hutchinson, M. R., Watkins, L. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200130109 · Cited by 521
Self-citationHäuser, W., Ablin, J., Fitzcharles, M.-A., Littlejohn, G., Luciano, J. V., Usui, C., & Walitt, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.22 · Cited by 505
Metadata
- Authors
- Watkins, L. R., Hutchinson, M. R., Rice, K. C., & Maier, S. F.
- Affiliations
- University of Colorado Boulder (US)
- National Institutes of Health (US)
- Corresponding author
- Watkins, Linda R.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 30
- Issue
- 11
- Pages
- 581-591
- ISSN
- 0165-6147 (ISSN-L)
- PMC
- PMC2783351
- OpenAlex
- W2103076324
- Cited by
- 438
- References
- 114
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 8 · 2023: 11 · 2022: 17 · 2021: 72 · 2020: 21 · 2019: 28 · 2018: 32 · 2017: 23 · 2016: 35 · 2015: 26 · 2014: 29 · 2013: 24 · 2012: 30
- FWCI
- 17.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- Merck Company Foundation
- American Australian Association
- International Association for the Study of Pain
- National Institutes of Health
- U.S. Food and Drug Administration
- National Health and Medical Research Council
- National Medical Research Council
- National Institute on Alcohol Abuse and Alcoholism
- National Institute on Drug Abuse (DA017670, K02DA015642, DA024044, DA 015642, R01DA023132, R01DA017670, K05DA024044)
- National Institute of Dental and Craniofacial Research (DE017782, R01DE017782)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- TLR4, neuropathic pain, opioid tolerance, opioid use disorder, respiratory depression, opioid analgesia, neuroinflammation
- MeSH terms
- Analgesics, Opioid, Animals, Clinical Trials as Topic, Humans, Neuralgia, Neuroglia, Pain, Drug Delivery Systems, Toll-Like Receptor 4, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review